Willkie Farr & Gallagher LLP today announced the arrival of Genevieve Dorment, who has joined the Firm as a partner in the Intellectual Property Department. She is based in New York. She was previously a partner at Simpson Thacher & Bartlett LLP.
“Genevieve is a skilled IP lawyer and a great addition to our transactional team, which has advised on some of the biggest and most innovative tech deals in recent years,” said Thomas Meloro, Chair of the Firm’s IP Department. “As our clients navigate a rapidly evolving market and changing regulatory landscape, Genevieve’s extensive experience and sophisticated knowledge will benefit our clients in their most challenging and complex tech transactions.”
Genevieve focuses her practice on intellectual property matters, serving as IP and privacy counsel for a broad range of public and private companies, private equity firms and charitable organizations. She has extensive experience advising clients on intellectual property, privacy and technology aspects of corporate transactions, including mergers and acquisitions, capital markets and financing transactions, licensing, strategic agreements and U.S. trademark applications and registrations. She also advises on intellectual property enforcement matters.
Genevieve commented: “Willkie’s experience in IP and technology-focused work, as well its distinguished corporate, private equity and transactional platforms, are a great fit for my practice. I am excited to join Willkie’s growing IP team.”
Genevieve’s arrival follows the addition earlier this year of San Francisco-based IP litigator Barrington Dyer. In 2021, the Firm also added IP litigators Krista Schwartz and Jonathan Patchen in San Francisco, and patent litigators Indranil Mukerji and Stephen Marshall in Washington, DC.
Willkie’s Intellectual Property Department represents clients from across the globe in litigation, transactions, counseling, and licensing on issues involving patents, trademarks, copyrights, domain names, and trade secrets. Our experience covers most industries and technologies, including pharmaceuticals, biologics, computer hardware and software, semiconductors, medical devices, consumer products, information and financial services, electronic devices, traditional and new media publishing, e-commerce, energy, sports, insurance, and music rights.
